Retiree Rx Benefit More Appealing Under Revised Waiver Guidance, Dow Says
Executive Summary
The Centers for Medicare & Medicaid Services is increasing its estimate of the number of Medicare beneficiaries that will be covered through employer-sponsored plans, Dow Chemical Government Relations, Tax & Benefits Director Janet Boyd said April 8
You may also be interested in...
Employers May Favor “Private Label” Plan Option Under Part D –Consultant
Contracting with a private label prescription drug plan or Medicare Advantage drug plan may be the best option for employers under Medicare Part D, Milliman Associate Actuary Frank Kopenski said at the Pharmaceutical Benefit Management Institute conference in Scottsdale, Ariz. March 31
Medicare Rx Employer Options Are Flexible But Without Windfalls, CMS Says
The Centers for Medicare & Medicaid Services is waiving several Medicare Part D plan requirements for employers to provide maximum flexibility for their participation in the drug benefit
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011